A 10‐year experience with treatment of high and standard risk Hodgkin disease: Six cycles of tailored BEACOPP, with interim scintigraphy, are effective and female fertility is preserved
Eldad J. Dann(Rambam Health Care Campus), Ron Epelbaum(University of Bern), Odelia Goor(Tel Aviv Sourasky Medical Center), Menachem Ben‐Shachar(Rambam Health Care Campus), Diana Libster, Jacob M. Rowe(Technion – Israel Institute of Technology), Irit Avivi(Tel Aviv Sourasky Medical Center), Zeev Blumenfeld(Rappaport Family Institute for Research in the Medical Sciences), Diana Gaitini(Technion – Israel Institute of Technology), Rachel Bar‐Shalom(Rambam Health Care Campus)
Cited by 34
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Anthracycline Dose Intensification in Acute Myeloid Leukemia
|New England Journal of Medicine|2009|907